Search - tctmd.com

Displaying 561 - 580 of 7240

Sort: Relevancy | Date

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

News Daily News

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

Yael L. Maxwell

July 18, 2024

Holistic Approach to Cardiac Surgery Can Sharply Cut Opioid Use

News Daily News

Holistic Approach to Cardiac Surgery Can Sharply Cut Opioid Use

July 18, 2024

FDA to Add New Diversity Requirements for Certain Clinical Studies

News Daily News

FDA to Add New Diversity Requirements for Certain Clinical Studies

July 15, 2024

Lower-Dose Edoxaban May Be an Option After Age 80: ENGAGE AF-TIMI 48 Analysis

News Daily News

Lower-Dose Edoxaban May Be an Option After Age 80: ENGAGE AF-TIMI 48 Analysis

July 12, 2024

Valvular Heart Disease Has a Diversity Problem

News Features

Valvular Heart Disease Has a Diversity Problem

Yael L. Maxwell

July 12, 2024

Ideal Aspirin Dose in Secondary Prevention Doesn’t Differ Much by Sex

News Daily News

Ideal Aspirin Dose in Secondary Prevention Doesn’t Differ Much by Sex

July 11, 2024

Stressors From All Sides Impact Women’s CV Risk, Review Asserts

News Daily News

Stressors From All Sides Impact Women’s CV Risk, Review Asserts

July 10, 2024

Going Global: Asia-Pacific Region Not Represented in Large Clinical Trials

News Daily News

Going Global: Asia-Pacific Region Not Represented in Large Clinical Trials

July 10, 2024

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

News Daily News

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Yael L. Maxwell

July 10, 2024

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

News Daily News

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Michael O'Riordan

July 09, 2024

LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year

News Conference News ACC 2024

NOW PUBLISHED - LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year

Yael L. Maxwell

July 03, 2024

TCTMD’s Top 10 Most Popular Stories for June 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2024

July 02, 2024

AHA Kicks Off Funding for Women’s Heart Health Amid Sex Gaps

News Daily News

AHA Kicks Off Funding for Women’s Heart Health Amid Sex Gaps

July 01, 2024

July 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

July 01, 2024

Rory Durand, MBBCh

News Featured Fellow

Rory Durand, MBBCh

Yael L. Maxwell

June 28, 2024

‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD

News Daily News

‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD

June 27, 2024

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

Semaglutide Has Similar Benefits in Women and Men With HFpEF

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

June 26, 2024

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

News Daily News

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

Michael O'Riordan

June 25, 2024

Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA

News Daily News

Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA

June 25, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.